Free shipping on all orders over $ 500

Canakinumab

Cat. No. M25286

All AbMole products are for research use only, cannot be used for human consumption.

Canakinumab Structure
Synonym:

Ilaris ACZ 885

Size Price Availability Quantity
100ug USD 200 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin.

Chemical Information
CAS Number 914613-48-2
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Luis Ortega-Paz, et al. Future Cardiol. Canakinumab for secondary prevention of coronary artery disease

[2] Paolo Sfriso, et al. Expert Rev Clin Immunol. Canakinumab for the treatment of adult-onset Still's disease

[3] Fabrizio De Benedetti, et al. N Engl J Med. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

[4] Naomi Schlesinger. Expert Opin Biol Ther. Canakinumab in gout

[5] Eugen Dhimolea. MAbs. Canakinumab

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Canakinumab, Ilaris ACZ 885 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.